HPV is associated with squamous cell cancers, which are common in HPV -
related anal cancer, but not in colorectal cancers.
«Based on epidemiological studies, the 9vHPV vaccine could prevent approximately 90 percent of cervical cancer, 90 percent of HPV - related vulvar and vaginal cancer, 70 to 85 percent of high - grade cervical disease in females, and approximately 90 percent of HPV -
related anal cancer and genital warts in males and females worldwide,» explained Anna R. Giuliano, Ph.D., Director of the Center for Infection Research in Cancer at Moffitt.
Not exact matches
A weakened immune system is thought to increase a person's risk of getting several
cancers caused by other viruses, including non-Hodgkin and Hodgkin lymphomas; anogenital
cancers, including penile, vaginal / vulvar, cervix, and
anal; Kaposi sarcoma; and possibly oral -
related cancers; and liver
cancer.
But a 2008 U.S. Centers for Disease Control and Prevention (CDC) assessment of the U.S.'s HPV -
related cancer burden found that each year the virus also likely caused about: • 7,400 cases (some 60 percent) of oral cavity and oropharynx
cancer (5,700 in men; 1,700 in women) • 3,000 cases of
anal cancer (1,100 in men; 1,900 in women) • 2,300 cases of vulvar
cancer • 800 cases (some 40 percent) of penile
cancer • 600 cases of vaginal
cancer During the course of the study period (1998 to 2003), the CDC found that the rates of HPV - associated oral cavity and oropharynx
cancer steadily rose about 3 percent annually.
Dr. Sturgis and his colleagues hope to provide data for such tests in clinical trials that will screen people at high risk for HPV -
related anal or oropharyngeal
cancers.